Back HIV/AIDS

HIV / AIDS

AASLD: Deaths Due to Hepatitis C Now Exceed HIV Deaths

Deaths related to hepatitis C virus (HCV) and its complications have exceeded deaths due to HIV/AIDS since 2007, according to an analysis by Centers for Disease Control and Prevention (CDC) researchers presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) last week in San Francisco.alt

Raltegravir (Isentress) Label Updated with New Side Effects Warning

The U.S. Food and Drug Administration (FDA) this week announced that the product information for the integrase inhibitor raltegravir (brand name Isentress) has been revised to include new warnings about potential skin reactions and other adverse events.alt

IDSA: Heart Problems Are Common Among People with HIV, but Largely Related to Modifiable Risk Factors

Structural and functional cardiac abnormalities were found in more than half of an HIV positive cohort in Washington, DC, according to a report at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA 2011) last month in Boston. Heart problems were often related to modifiable factors such as obesity and diabetes, suggesting that lifestyle changes may lower the risk.

IDSA: Capsaicin Patch Reduces Pain Due to HIV-Associated Neuropathy

A patch containing 8% capsaicin -- a compound derived from chili peppers -- significantly relieved the pain of nerve damage related to HIV or its treatment, investigators reported at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA 2011) last month in Boston.alt

How Much Can Early Treatment Reduce HIV Transmission Among Discordant Couples?

Treating the HIV positive partner in serodiscordant couples can decrease the risk of transmitting the virus, but the extent of the reduction will likely vary from country to country based on population size, HIV prevalence, and number of discordant couples, according to a mathematical model study described in the October 11, 2011, advance online edition of AIDS.alt

IDSA: Tenofovir Not Linked to Increased Kidney Risk in HIV+ Veterans Study

Use of tenofovir (Viread, also in the Truvada and Atripla coformulations) was not associated with a higher risk of kidney toxicity compared with other antiretroviral agents, according to a study presented at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA 2011) last month in Boston.

Teens Should Receive Routine HIV Testing, Says American Academy of Pediatrics

Adolescents and young adults should be offered risk reduction counseling and routine testing in an effort to prevent HIV transmission and to initiate treatment in a timely manner, according to a recent policy statement from the American Academy of Pediatrics (AAP).alt